EUVIMEDEUVIMED entdecken
Historischer BeitragÜbersichtsarbeitOpen Access · CC BY 4.0

Sixty Years at the Rega Institute

Erik De Clercq iD

Viruses · 2025

DOI: 10.3390/v17020222 ↗

Kurz gefasst

Historischer Beitrag in der Zeitschrift Viruses, 2025. Verfasst von Erik De Clercq. Beteiligte Einrichtung: Rega Institute for Medical Research, KU Leuven, Herestraat 49, B-3000 Leuven, Belgium. Hauptthemen laut MEDLINE: Antiviral Agents. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

I started my research career (in 1965) on interferon by identifying polyacrylic acid (PAA) as an interferon inducer. Poly(I).poly(C), discovered by Maurice Hilleman’s group, proved to be more potent as an interferon inducer, and through its mRNA, we were able to clone and express human β-interferon. The discovery of the reverse transcriptase (RT) by Temin and Baltimore (in 1970) brought me to the detection of suramin as a powerful RT inhibitor and enabled Sam Broder and his colleagues to identify suramin as the first inhibitor of HIV replication. In this capacity, it was subsequently superseded by AZT and other 2′,3′-dideoxynucleoside (ddN) analogs, including d4T. In collaboration with Antonín Holý, we discovered several acyclic nucleoside phosphonates as potent inhibitors of both HIV and HBV (hepatitis B virus) replication. In collaboration with Paul Janssen, we identified various non-nucleoside RT inhibitors (NNRTIs) of HIV-1 replication. Of the nucleotide RT inhibitors (NtRTTs), tenofovir emerged as the most promising congener. It was derivatized to its oral prodrugs TDF and TAF. To enhance their efficacy, they were combined with other anti-HIV drugs, and two of them were pursued (and found efficacious) in the Pre-Exposure Prophylaxis (PrEP) of HIV infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsHumansHistory, 20th CenturyHIV-1Virus ReplicationHistory, 21st CenturyReverse Transcriptase InhibitorsHIV InfectionsHepatitis B virusAnti-HIV Agents

Stichwörter der Autor:innen

ANPsNNRTTsNRTTsNtRTTsPrEPTAFTDFinterferonpoly(I).poly(C)suramin

Substanzen

Antiviral AgentsReverse Transcriptase InhibitorsAnti-HIV Agents

Autor:innen und Institutionen

  • Rega Institute for Medical Research, KU Leuven, Herestraat 49, B-3000 Leuven, Belgium.

ORCID-Profile: Erik De Clercq

Zitieren

APA

De Clercq, E. (2025). Sixty Years at the Rega Institute. Viruses. https://doi.org/10.3390/v17020222

Vancouver

De Clercq E. Sixty Years at the Rega Institute. Viruses. 2025. doi:10.3390/v17020222

BibTeX
@article{DeClercq2025,
  author = {De Clercq, Erik},
  title = {Sixty Years at the Rega Institute},
  journal = {Viruses},
  year = {2025},
  doi = {10.3390/v17020222}
}
Kostenlos starten →